Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Electrical Fingerprint of Extracellular Vesicles Could Detect Pancreatic Cancer

By LabMedica International staff writers
Posted on 10 Sep 2026

Pancreatic cancer is often diagnosed only after it has spread, contributing to a five-year survival rate of 13%. More...

Standard blood-based analyses can struggle to distinguish tumor signals from the background of normal cellular material. Extracellular vesicles (EVs) in circulation may carry tumor-derived information, but isolating relevant subsets remains difficult. New findings demonstrate that an electrical “fingerprint” on EVs can be exploited to enrich cancer-associated signals.

Rice University researchers developed a microfluidic electrophoresis device that separates extracellular vesicles by electrical charge to reveal pancreatic cancer–associated particles. The approach isolates a subpopulation enriched for a stronger negative charge, offering a way to study disease signals otherwise masked in bulk measurements. The work targets a diagnostic challenge where tumor-derived EVs are greatly outnumbered by vesicles released from healthy tissues.

The technology capitalizes on a physical trait that EVs already possess: surface electrical charge. In pancreatic cancer cell models, activating mutant KRAS increased EV release and produced vesicles with a stronger negative charge. The electrical signature was attributed to DNA and other materials present on the outer surface of EVs. The device moves minute amounts of blood serum through narrow channels and uses an electric field to collect the more negatively charged EV fraction.

The team evaluated the method using 112 human samples spanning healthy individuals, patients with pancreatic cancer and patients with pancreatitis. Measuring the average charge of all EVs in blood did not distinguish cancer from non-cancer samples because tumor-related particles were diluted by vesicles from normal tissues. After charge-based separation, pancreatic cancer samples showed greater enrichment of the highly negative EV population, revealing differences that bulk measurements had obscured.

The findings were published Sept. 1 in ACS Nano. Collaborators included The University of Texas MD Anderson Cancer Center, Helios University Hospital Wuppertal and Heidelberg University. According to the investigators, many existing EV methods rely on size, density or affinity capture, whereas this device enables targeted collection based on inherent electrical properties. The results suggest that sorting particles by a physical characteristic can uncover informative signals that average measurements may overlook.

“The bloodstream is an incredibly crowded environment, so the challenge is not simply finding tiny particles but identifying the ones that carry meaningful information. Our results show that electrical charge gives us another way to sort through that noise and bring a cancer-associated signal into view,” said Kshipra Kapoor, the study’s co-lead author and a Rice electrical and computer engineering doctoral alumna.

“An electrocardiogram turns the heart’s electrical activity into information doctors can use. In a similar spirit, our work suggests that the electrical properties of extracellular vesicles could one day provide another way to read biological information from cancer,” said Kapoor.

Related Links:
Rice University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.